Cuin a bhios Neurocrine Biosciences, Inc. a 'foillseachadh aithris prothaid is call?
Tha aithris prothaid is call Neurocrine Biosciences, Inc. air fhoillseachadh aon uair sa cheathramh; chaidh an aithisg mu dheireadh de thoraidhean ionmhais Neurocrine Biosciences, Inc. fhoillseachadh air 31/03/2021.
Dè a 'phrothaid bho na h-earrannan de Neurocrine Biosciences, Inc.?
B 'e tuairmse de chosnaidhean gach roinn de Neurocrine Biosciences, Inc. 0.33 $ anns an aithisg ionmhais mu dheireadh.
Cuin a dh'fhoillsicheas Neurocrine Biosciences, Inc. an ath aithris prothaid agus call?
Bidh an ath aithisg air a 'chunntas prothaid is call Neurocrine Biosciences, Inc. air An t-Ògmhios 2024.
Neurocrine Biosciences, Inc. cosnadh gach cuibhreann - feartan ionmhais a ’chompanaidh a rèir meud a luach. Cosnadh gach cuibhreann - luach air a thomhas: tha a ’phrothaid iomlan airson na h-ùine aithris air a roinn leis an àireamh de earrannan a th’ ann. Gu follaiseach, tha Neurocrine Biosciences, Inc. cosnadh gach cuibhreann na thaisbeanair caochlaideach airson ùine ionmhais sònraichte. Prothaid Neurocrine Biosciences, Inc. - prothaid iomlan airson na h-ùine ionmhais aithriseach.
|
Brabac Neurocrine Biosciences, Inc.
Tha Neurocrine Biosciences, Inc. prothaid iomlan airson iomradh a-mhàin agus chan eil e inntinneach do luchd-earrannan fa leth. Nas cudromaiche tha obrachadh a-mach gach cuibhreann. Tha an luach seo mar bhunait airson a bhith a ’tomhas earrannan agus tha iarrtas nas motha ann bho aire luchd-earrannan. Tha ceann-latha na h-aithisg prothaid Neurocrine Biosciences, Inc. air a shuidheachadh le riaghladh na buidhne. Bidh gach ceann-latha de Neurocrine Biosciences, Inc. a ’freagairt ri loidhne sa chlàr seirbheis.
|
Prothaid ràitheil Neurocrine Biosciences, Inc.
Cosnadh gach cuibhreann Neurocrine Biosciences, Inc. air a thomhas le bhith a ’roinn teachd-a-steach lom leis an àireamh de earrannan sa chompanaidh. Tha buannachdan gach cuibhreann de Neurocrine Biosciences, Inc. air a dhearbhadh airson ùine ionmhais stèidhichte agus a rèir toraidhean nan aithrisean ionmhais air prothaid na companaidh. Gheibhear Neurocrine Biosciences, Inc. cosnadh gach cuibhreann airson na h-ùine aithris mu dheireadh anns a ’chlàr againn (an t-sreath as àirde) no graf (an colbh as fhaide air falbh). Is e prothaid ràitheil Neurocrine Biosciences, Inc. am prìomh sheòrsa aithrisean ionmhais am measg chompanaidhean.
|
|
Ceann-là aithisg NBIX
|
Tuarastal airson gach roinn
Tha tuarastalan gach co-roinn air an tomhas le bhith a 'roinneadh teachd-a-steach (no prothaid) lìon le àireamh nan earrannan den chompanaidh.
|
Atharrachadh airson na bliadhna %
|
|
31/03/2021 |
0.33 USD |
- |
|
31/12/2020 |
3.58 USD |
+922.86% ↑ |
|
30/09/2020 |
-0.62 USD |
-210.714% ↓ |
|
30/06/2020 |
0.81 USD |
+50% ↑ |
|
31/12/2019 |
0.35 USD |
+310.58% ↑ |
|
30/09/2019 |
0.56 USD |
+39.89% ↑ |
|
30/06/2019 |
0.54 USD |
-165.562% ↓ |
|
31/03/2019 |
-1.12 USD |
-67.0652% ↓ |
|
31/12/2018 |
0.19 USD |
+0.62% ↑ |
|
30/09/2018 |
0.52 USD |
-195.148% ↓ |
|
30/06/2018 |
-0.07 USD |
-74.675% ↓ |
|
31/03/2018 |
-0.47 USD |
-58.822% ↓ |
|
31/12/2017 |
0.07 USD |
-132.178% ↓ |
|
30/09/2017 |
-0.13 USD |
-15.347% ↓ |
|
30/06/2017 |
-0.68 USD |
-25.535% ↓ |
|
31/03/2017 |
-0.9 USD |
-61.268% ↓ |
|
31/12/2016 |
-0.51 USD |
-43.026% ↓ |
|
30/09/2016 |
-0.43 USD |
-55.546% ↓ |
|
30/06/2016 |
-0.46 USD |
-41.976% ↓ |
|
31/03/2016 |
-0.22 USD |
-5% ↓ |
|
31/12/2015 |
-0.34 USD |
-24.298% ↓ |
|
30/09/2015 |
-0.4 USD |
-16.832% ↓ |
|
30/06/2015 |
-0.28 USD |
-36.535% ↓ |
|
31/03/2015 |
-0.01 USD |
-35.417% ↓ |
|
31/12/2014 |
-0.26 USD |
-28.768% ↓ |
|
30/09/2014 |
-0.21 USD |
-3.571% ↓ |
|
30/06/2014 |
-0.18 USD |
-6.235% ↓ |
|
31/03/2014 |
-0.17 USD |
-7.742% ↓ |
|
31/12/2013 |
-0.16 USD |
-54.566% ↓ |
|
30/09/2013 |
-0.17 USD |
-73.896% ↓ |
|
30/06/2013 |
-0.18 USD |
-85.378% ↓ |
|
31/03/2013 |
-0.18 USD |
-96.269% ↓ |
|
31/12/2012 |
0.14 USD |
-119.048% ↓ |
|
30/09/2012 |
-0.05 USD |
-459.44% ↓ |
|
30/06/2012 |
-0.01 USD |
-325.909% ↓ |
|
31/03/2012 |
-0.01 USD |
-899.55% ↓ |
|
31/12/2011 |
0.02 USD |
-155.533% ↓ |
|
30/09/2011 |
0.56 USD |
+307.11% ↑ |
|
30/06/2011 |
0.04 USD |
-136.924% ↓ |
|
31/03/2011 |
0.05 USD |
-122.089% ↓ |
|
31/12/2010 |
0.04 USD |
-113.989% ↓ |
|
30/09/2010 |
0.06 USD |
-113.259% ↓ |
|
30/06/2010 |
-0.09 USD |
-56.668% ↓ |
|
31/03/2010 |
-0.19 USD |
-37.896% ↓ |
|
31/12/2009 |
-0.2 USD |
-44.758% ↓ |
|
30/09/2009 |
-0.21 USD |
-31.348% ↓ |
|
30/06/2009 |
-0.39 USD |
-22.807% ↓ |
|
31/03/2009 |
-0.51 USD |
-29.638% ↓ |
|
31/12/2008 |
-0.75 USD |
-41.418% ↓ |
|
30/09/2008 |
-0.46 USD |
-34.434% ↓ |
|
30/06/2008 |
-0.55 USD |
-28.737% ↓ |
|
31/03/2008 |
-0.55 USD |
-16.483% ↓ |
|
31/12/2007 |
-0.89 USD |
-9.984% ↓ |
|
30/09/2007 |
-0.72 USD |
-14.469% ↓ |
|
30/06/2007 |
-0.69 USD |
-0.868% ↓ |
|
31/03/2007 |
-0.68 USD |
-4.515% ↓ |
|
31/12/2006 |
-0.39 USD |
-8.00771% ↓ |
|
30/09/2006 |
-1.03 USD |
-152.864% ↓ |
|
30/06/2006 |
-0.73 USD |
-67.277% ↓ |
|
31/03/2006 |
-0.69 USD |
-1.0294% ↓ |
|
31/12/2005 |
-0.65 USD |
-50.346% ↓ |
|
30/09/2005 |
0.68 USD |
-223.254% ↓ |
|
30/06/2005 |
-0.15 USD |
-11.546% ↓ |
|
31/03/2005 |
-0.51 USD |
-42.39% ↓ |
|
31/12/2004 |
-0.57 USD |
-59.785% ↓ |
|
30/09/2004 |
-0.05 USD |
-7.559% ↓ |
|
30/06/2004 |
-0.31 USD |
-29.824% ↓ |
|
31/03/2004 |
-0.35 USD |
-3.239% ↓ |
|
31/12/2003 |
0.09 USD |
-83.529% ↓ |
|
30/09/2003 |
-0.31 USD |
-55.522% ↓ |
|
30/06/2003 |
-0.33 USD |
-44.39% ↓ |
|
31/03/2003 |
-0.43 USD |
-42.132% ↓ |
|
31/12/2002 |
-1.27 USD |
- |
|
30/09/2002 |
-0.66 USD |
- |
|
30/06/2002 |
-0.65 USD |
- |
|
31/03/2002 |
-0.52 USD |
- |
Is e Neurocrine Biosciences, Inc. cosnadh ràitheil gach cuibhreann prothaid tuairmseach a ’chompanaidh. Tha brìgh eadar-mheadhanach aca am measg luchd-anailis. Ach tha cosnadh bliadhnail gach cuibhreann air leth cudromach. Is e a ’phrothaid ràitheil mu dheireadh Neurocrine Biosciences, Inc. an-diugh a’ phrothaid a chaidh ainmeachadh gu h-oifigeil airson a ’cheathramh iomraidh mu dheireadh. Tha atharrachadh ann an prothaid Neurocrine Biosciences, Inc. airson na bliadhna na luach àireamhaichte airson fiosrachadh a bharrachd a tha a ’sealltainn an atharrachadh sa cheud de phrothaid leis an aon eadar-ama den bhliadhna mu dheireadh. Chan eil atharrachadh ann an Neurocrine Biosciences, Inc. prothaid ràitheil airson na bliadhna cho cudromach ri atharrachadh ann an prothaid bliadhnail Neurocrine Biosciences, Inc. an coimeas ris an-uiridh.
Airson goireasachd tuigse agus anailis, bidh sinn a ’foillseachadh an atharrachaidh ann am prothaid mar cheudad. Tha eachdraidh prothaid Neurocrine Biosciences, Inc. airson na bliadhnaichean a dh ’fhalbh agus amannan aithris anns a’ chlàr “Prothaid ràitheil”. Neurocrine Biosciences, Inc. tha eachdraidh cosnaidh ràitheil ri fhaighinn air-loidhne thairis air na 10 bliadhna a dh ’fhalbh. Tha Neurocrine Biosciences, Inc. stòr-dàta prothaid air-loidhne airson amannan ùine air a chur ri chèile bho stòran oifigeil dearbhte fad na h-ùine.
|
